Jackpharma Inc.

What Jackpharma Inc. does

Jackpharma Inc. is a Filipino-owned pharmaceutical marketing and distribution company founded in June 2015, headquartered at Goldhill Tower, Greenhills, San Juan City, Metro Manila. The company markets and distributes a portfolio of 17+ prescription pharmaceuticals, food supplements, and medical devices across seven therapeutic categories: bone and joint care, viscosupplements, gastro-diabetic care, antibacterials, pain management, anti-rheumatics, and oto-ophthalmic solutions. All products are FDA-approved and sourced from manufacturers certified to cGMP, PIC/S, and ISO standards; Jackpharma does not own manufacturing but holds exclusive distribution and in-licensing rights for brands including DALZEN (Ritzen), the full Vendiz Pharmaceutical portfolio, and viscosupplement lines.

The business operates a multi-channel go-to-market model: a direct field sales force of medical representatives calls on orthopedic surgeons, rheumatologists, endocrinologists, gastroenterologists, family physicians, and rehabilitation specialists across Metro Manila and Rizal; products are stocked nationally through Mercury Drug Corporation and other retail pharmacies; and direct-to-consumer sales run through the jackpharma.shop e-commerce storefront and Mycofam Pharma online marketplace. Pricing is unit-based in Philippine pesos across affordable generic and supplement tiers (most SKUs PHP 10–PHP 560), with select viscosupplements sold on a contact-for-price basis. The company supplements sales with medical-society event participation (PRA, POA, OSPFI, HSP, AACE Philippines), webinar-based product education, and disaster-relief donations to LGUs.

Jackpharma is privately held with approximately 25 employees, family-founded by Jacko Hernandez, Michael Bato, and Glenn Hu under the presidency of Meneleo C. Hernandez Jr. The company reports +41% revenue growth in 2023, expanded its brand portfolio via the September 2024 Vendiz in-licensing agreement, and is actively recruiting field sales personnel in 2025 to extend geographic coverage within the Philippines.

Name

Jackpharma Inc.

Legal name

Jackpharma Inc.

Website

https://jackpharma.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Jackpharma Inc. is a Filipino-owned pharmaceutical marketing and distribution company founded in 2015, marketing 17+ prescription and supplement brands across seven therapeutic categories to healthcare professionals, retail pharmacies, and consumers in the Philippines.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmacies and Drug Retailers (45611)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical distribution
• Prescription medicines
• Dietary supplements
• Bone and joint care
• Pain management

Headquarters

HQ city

San Juan City

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Supply Chain, Operations, Technology or R&D, Others

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from the sale of prescription medicines and dietary supplements across therapeutic categories including bone and joint care, pain management, anti-rheumatics, viscosupplements, oto-ophthalmic solutions, gastro-diabetic care, and antibacterials. Products sold through field sales force to healthcare professionals, retail pharmacies, and direct-to-consumer e-commerce.
2. Digital Marketing Services (Mycofam Pharma): Mycofam Pharma serves as the digital marketing arm for Jackpharma Inc., catering to consumer needs and managing the jackpharma.shop e-commerce platform and mycofampharma.com online marketplace.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels6 records

Core offering

Jackpharma Inc. markets and distributes FDA-approved prescription pharmaceuticals and over-the-counter food supplements sourced from cGMP Certified, PIC/S Compliant and ISO Certified manufacturers. Its portfolio spans bone and joint care, viscosupplements, gastro-diabetic care, pain management, anti-rheumatics, oto-ophthalmic solutions, and antibacterial categories, sold primarily through a Medical Representative field force to healthcare professionals and through retail pharmacies including Mercury Drugstore, with a direct-to-consumer e-commerce storefront at jackpharma.shop.

Product overview

Jackpharma Inc. is a Filipino pharmaceutical marketing and distribution company founded in June 2015, offering a diversified portfolio of prescription pharmaceuticals and food supplements across multiple therapeutic categories. The product portfolio includes: Oto-Ophthalmic Solutions (Otixin, Vendicom, Hypromax, Maxoptic, Vendiflox, Venpred, Vitaclear); Anti-rheumatics (Urix, Hydroxyjac, Xtrate); Pain Management (Dalzen, Diclojack Gel, Neurojack, Orphegesic Forte, Empred-40); Antibacterial (Doxicon); Gastro-Diab Care (Sitajack-M, Sporlac Plus); Bone & Joint Care (Calpro Plus, Artipotect); and Viscosupplements/Intra-articular Hyaluronic Acid Injections (HAppyCross, Hyal Forte, Optivisc Single, Optivisc). Products are sourced from manufacturers that are cGMP Certified, PIC/S Compliant, and ISO Certified. The company operates an online store at jackpharma.shop.

Differentiator

Problem solved

Functional benefit

Products and services

• Otixin

Quantifiable outcome

• 41% revenue growth in 2023

Named customers1 record

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Vendiz Pharmaceutical, Inc. (VPI)coreStrategic or Co-development Partner · 1 September 2024In-licensing agreement effective September 1, 2024 for exclusive marketing and distribution of entire Vendiz product portfolio including 17+ brands. Notable brands include DOXICON (Doxycycline 100mg), QUADROTOPIC CREAM, and VITACLEAR (multivitamins + lutein + zinc + selenium). Creates positive synergy to grow overall JPI business with existing and new customers.
• Ritzen Philippines, Inc.minorChannel Partner/ Reseller/ Distributor · 1 June 2022Exclusive distributorship and marketing agreement for DALZEN (Serrapeptase 10mg) effective June 1, 2022 in Philippines. Ritzen Philippines is the maker of Dalzen.
• Mycofam PharmacoreChannel Partner/ Reseller/ DistributorDigital marketing arm for Jackpharma Inc. catering to consumer needs. Manages mycofampharma.com online marketplace and jackpharma.shop e-commerce platform. Founded with Jackpharma in 2015, promoting products for pain management and osteoarthritis to healthcare practitioners.
• Medethix Inc.minorChannel Partner/ Reseller/ DistributorPartnership for Molnupiravir distribution in Philippines. Appointed by Medethix to help reach wider range of doctors and patients with COVID-19 treatment. Medethix received Compassionate Special Permits from Philippine FDA for Molnupiravir.
• Aurobindo PharmaminorOthersLeading US-FDA approved Indian manufacturer with voluntary in-licensing deal with MSD for Molnupiravir production. Partnered with Medethix Inc. and Jackpharma to supply Molnupiravir to Philippines.
• Hepatology Society of the PhilippinesminorStrategic or Co-development PartnerPartnership for hepatitis B awareness and patient support. Donated Baracross (Entecavir) to support HSP's B AWARE awareness program for Chronic Hepatitis B patients, particularly during COVID-19 community quarantine.
• American College of Clinical Endocrinologists Philippine Chapter (AACE)minorStrategic or Co-development PartnerPartnership with AACE Philippines Chapter President Theresa Marie Valez-Faller, MD for Project Noah pandemic preparedness. Donated CALPRO PLUS supplements and PPE to AACE frontliner members.
• Philippine Rheumatology Association (PRA)coreStrategic or Co-development PartnerAnnual convention participation and ongoing partnership with PRA. JPI introduced latest products for Lupus and Rheumatoid Arthritis at PRA conventions. Full team participation including District Managers at annual and midyear conventions.
• Philippine Orthopaedic AssociationcoreStrategic or Co-development PartnerAnnual convention participation at Edsa Shangri-La Hotel (November 2025) and Mid-Year Convention at dusitD2 Davao Hotel (April-May 2025). Booth presence for product showcasing and relationship building with orthopedic surgeons.
• Osteoporosis Society of the Philippines Foundation Inc. (OSPFI)minorStrategic or Co-development PartnerFirst-time participation in OSPFI convention held at Marco Polo Ortigas (October 2025). Partnership for bone health advocacy and patient care improvement.
• Various LGUs and Relief OrganizationsminorOthersPartnership with Local Government Units for disaster relief including Cebu Provincial Government, AFP units, Marikina, Pasig, Daet, Ilagan, San Juan City, Caloocan, and Pangasinan. Donated doxycycline to AFP units for leptospirosis protection.
• Clinica ManilaminorOthersExhibitor participation at Clinica Manila Health and Wellness Fiesta celebrating 30th year anniversary.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Others

• Aurobindo Pharma: Indian generic and specialty pharmaceutical manufacturer that partnered with Medethix and Jackpharma to supply Molnupiravir to the Philippines. Comparable as an enabling manufacturing partner in Jackpharma's distribution network.
• Mercury Drug Corporation: Philippines' largest retail pharmacy chain and a key distribution channel for Jackpharma products. Functions as a customer/channel rather than direct competitor but ecosystem-adjacent.

Direct peers

• Pascual Laboratories, Inc. Filipino-owned pharmaceutical company marketing branded prescription and OTC products across multiple therapeutic categories in the Philippines. Highly comparable in operating model (Filipino-owned, branded pharma marketing) and customer base.
• Amherst Laboratories (Unilab subsidiary): Philippine pharmaceutical manufacturer and marketer operating as part of the Unilab group, focused on branded generics and specialty prescription products. Comparable therapeutic breadth and Philippine market focus.
• Medethix Inc. Philippine pharmaceutical distribution company that partnered with Jackpharma on Molnupiravir (COVID-19). Operates a similar asset-light distribution model bringing third-party-manufactured innovator products to the Philippine market.
• RITEMED Philippines: Philippine-focused pharmaceutical distributor/marketer with a portfolio of branded generic and innovator products distributed through retail pharmacy chains including Mercury Drug. Comparable as a domestic Filipino pharma distribution competitor.

Regional players

• Lloyd Laboratories, Inc. Philippine-based pharmaceutical manufacturer and marketer of branded generics across multiple therapeutic areas. Comparable as a domestic Filipino pharma marketing organization competing in overlapping categories.

Broad incumbents

• United Laboratories (Unilab): The largest Filipino-owned pharmaceutical company offering a broad branded prescription, OTC, and consumer health portfolio distributed through Mercury Drug and other channels nationwide. Directly comparable as a Filipino pharma marketing/distribution competitor but at vastly greater scale.
• Novartis Philippines: Multinational pharmaceutical company with Philippine operations marketing branded prescription products across specialty therapeutic categories. Comparable HCP-targeted specialty pharma motion.
• Pfizer Philippines: Philippine subsidiary of Pfizer, marketing a broad innovator pharmaceutical portfolio through field sales to healthcare professionals. Overlaps with Jackpharma's physician-targeted motion but at vastly greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/jackpharmainc
• LinkedInlinkedin.com/company/jackpharma-inc

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jackpharma Inc.